Coya Therapeutics, Inc. (COYA) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)

A side-by-side comparison of Coya Therapeutics, Inc. and Corbus Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COYA vs CRBP

growth of $100 · dividends reinvested · last 4y
COYA +6.1% (+1.5%/yr)CRBP +77.3% (+15.4%/yr)CRBP compounded faster over this window
05001k2kStart $1002023202420252026$106$177
COYA CRBP

COYA vs CRBP: by the numbers

  • •COYA is the larger company ($114M vs $109M market cap).
  • •Both run net losses; CRBP's is the smaller (0.00% vs -270.22% net margin).

Metrics side by side

Valuation

MetricCOYACRBP
P/S ratio14.22N/A
P/B ratio0.001.07

Profitability

MetricCOYACRBP
Gross margin99.91%0.00%
Operating margin-255.05%0.00%
Net margin-270.22%0.00%
ROE-0.05%-99.67%
ROIC-0.05%-101.30%

Growth (annualized)

MetricCOYACRBP
Total return CAGR (5Y)N/A-28.32%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.